Dual and Triple Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data Current Obesity Reports Springer Nature Link Current Strategies in Managing Obesity STRIVE Obesity Semaglutide vs Tirzepatide Pro Peptides Plus CagriTirz (Cagrilintide + Tirz) >99% Purity Retatrutide vs. Tirzepatide: The Next Gen GLP 1 Showdown Cagrilintide is an amylin analogue that helps regulate appetite. In a randomized trial of over 3400 patients who were overweight or obese and had 1 weight related complication, individuals assigned to a combination